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Exosomes derived from the clinical grade neural stem cell line CTX (ReNeuron) are the basis of a new class of 
therapy for the treatment of degenerative disorders. Thus far we have generated CTX-derived exosomes at 
research scale in 2D planar cultures. Now the cell culture process needs to be scaled up in order to deliver 
commercially relevant quantities of exosomes that have the correct quality attributes. To meet these demands, 
CTX cells, which are adherent and habitually grown in a 2D static environment, must be adapted for growth in 
3D agitated bioreactor systems.  
 
In this research we show that CTX cells can be grown on microcarriers in 100mL spinner flasks, a model 
bioreactor system, with a view to achieving industrial scale cultivation of exosomes. This was informed by 
preliminary microscale screening of different microcarrier substrates using a low-volume closed system under 
automated perfusion. Furthermore an innovative semi-automated technique for imaging and analysis is applied 





Using this system we were able to reduce a vast panel of commercially available microcarriers by >80% prior to 
any scale-up activities, thereby minimising experimental time, cost and risk of failure. We were then able to 
validate our candidate conditions in 100mL spinner flasks, achieving our target cell population of 60,000 
cells/cm2 in 4 days, representative of our static 2D system. The resultant exosomes were purified and analysed 
in terms of particle number, size distribution and CD markers to assist us in assigning critical quality attributes. 
 
Having effectively adapted our cells to our model bioreactor system, we now look to scale-up further and 
succeed in industrial scale cultivation of exosomes. 
 
 
Figure 1 – Validation of CTX cell growth on microcarriers in 100mL spinner flasks in which target cell population 
of 60,000 cells/cm2 within 4 days was achieved in-line with 2D culture system  
